Products
Cervical Cytology Instruments
Flexibility and efficiency for actionable clinical results
Discover BD cytology testing instruments
Flexible solutions for any volume and every paradigm
Cytology Sample Preparation
BD’s cytology sample preparation methodology utilises a proprietary cell enrichment processing to remove obscuring elements from the sample, both improving cervical disease detection and reducing the incidence of unsatisfactory results.
Low-mid volume testingCytology Slide Preparation and Staining
Fully automated slide processing from sample transfer to staining. The BD Totalys™ SlidePrep offers discreet individual slide staining with reduced risk of contamination whilst ensuring sample chain of custody.
Cytology Imaging and Screening
The BD FocalPoint™ GS Imaging System improves cervical cancer detection and screening efficiency by ranking slides and prioritizing the review of locations of interest on both BD SurePath™ Liquid-based Pap Test and conventional preparations.
Meet the BD PrepMate™ automated accessory
Precise specimen transfer directly from BD SurePath™ Collection Vials for BD's proprietary cell enrichment process
Efficiency
Providing simple and fast automation
- Automated process handling 1 to 12 samples per cycle1
- Predictably mixes, aspirates and dispenses a defined volume of specimen
- Eliminates manual cap removal, reducing the risk of contamination
- Fast sample processing, taking less than 5 minutes to run 12 samples
- Simple user interface and small footprint
1. BD PrepMate™ automated accessory Operator’s Manual [500005571]. Franklin Lakes, NJ: Becton, Dickinson and Company; 2020.
2. Nance KV. Evolution of Pap testing at a community hospital: a ten year experience. Diagn Cytopathol. 2007 Mar;35(3):148-53.
3. Sweeney BJ, Haq Z, Happel JF, Weinstein B, Schneider D. Comparison of the effectiveness of two liquid-based Papanicolaou systems in the handling of adverse limiting factors, such as excessive blood. Cancer. 2006 Feb 25;108(1):27-31.
4. Moriarty A, Clayton A, Zaleski S et al. Unsatisfactory Reporting Rates: 2006 Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology. Arch Pathol Lab Med. 2009;133(12):1912–1916
Meet the BD Totalys™ MultiProcessor
Designed to meet the needs of evolving cervical cancer screening
Features
- Automates the unique BD cellular enrichment process for BD SurePath™ Liquid-based Pap test
- Optional, customizable aliquots supports ancillary molecular testing, including the BD Onclarity™ HPV Assay
- Full chain of custody from collection vial to sample outputs
- Intuitive touch-screen interface puts the entire process at your fingertips
Technical Specifications
Cytology
Cervical cancer
Fully automated
Integrated data management
Liquid-based cytology
Aliquot option
Intuitive interface
Electrical specifications
| Voltage | 100-240 VAC ± 10% |
| Current | 10-6 A |
| Input line frequency | 47-63 Hz |
Operating conditions
| Temperature | 18°C – 30°C / 64.4°F – 86°F |
| Humidity | 20% to 80%, non-condensing |
| Locations | Level surface; no direct heat |
| Altitude | Up to 2000m (6562ft) |
| Light conditions | From dark to 15000 lux; no direct light |
Specimen handling
| Specimen collection type | BD SurePath™ Collection Vial |
| Sample volume | 6mL or 8mL aliquot drawn for cytology testing Customizable molecular aliquots from 0.25 mL – 1.5 mL*/td> |
| On-board sample capacity | Up to 96 patient samples (6 trays x 16 samples) |
| Positive sample identification | 2D barcodes on all patient vials and instrument consumables ensure chain of custody |
*One transfer per sample only
Performance
- Processes BD SurePath™ Liquid-based Pap test and Non-Gynaecological samples
- Fully integrates with the BD Totalys™ MultiProcessor to maintain continuous chain-of-custody
- Consistent results with staining in individual chambers using fresh reagents for every sample
- Accurate reagent pipetting and precise timing for each sample reduces process variability
* When used with the BD Totalys™ MultiProcessor
Performance
- Statistically significant increases in disease detection over the manual screening method1
- Directed QC technology™ flags up to 15% of highest ranked cases diagnosed as negative for additional review to assist in the reduction of false negative diagnoses1
- ‘No Further Review’ functionality enables triaging of up to 25% of lower ranked slides without the requirement for secondary screening
- Compared to manual screening, the BD FocalPoint™ GS Imaging System was associated with a 42% overall decrease in ASC / SIL ratio1, leading to more accurate diagnosis.
ACS, atypical squamous cells; HSIL, high-grade squamous intraepithelial lesions; LSIL, low-grade squamous intraepithelial lesions.
1. BD FocalPoint™ GS Imaging System Product Insert. 2. Bowditch R.C, Clarke J.M, Baird P.J, Greenberg M.L. Diagn Cytopathol. 2012;40(12):1093-1099.